Metrion Biosciences Limited and Enamine Ltd have partnered to enhance Metrion’s High Throughput Screening (HTS) services with access to Enamine’s compound libraries. Enamine’s collection is the largest globally, offering both CNS and ion channel-focused target libraries. These libraries can be split into screening sets for increased flexibility, efficiency, and cost-effectiveness in hit expansion and SAR studies. Metrion’s team of experts provides specialist advice to researchers for strategic choices in screening, while Enamine offers additional support in hit resupply, analoging, and custom synthesis. This collaboration aims to maximize R&D budgets and support ion channel drug discovery projects effectively.
Source link
Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries
